Prognosis of infections in elderly patients with haematological diseases

Supportive Care in Cancer

Volumn 4, Issue 1, 1996, Pages 46-50

  Rossini, Fausto ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

Aged; Immunocompromised host; Infection; Leukaemia

Indexed keywords

ANTIINFECTIVE AGENT;

AGE; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IMMUNE DEFICIENCY; INFECTION; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOMA; MALE; MIDDLE AGED; NEUTROPHIL; PROGNOSIS; PROSPECTIVE STUDY;

AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION; LEUKEMIA; LEUKOCYTE COUNT; LYMPHOMA; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0029688273     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01769875     Document Type: Article

References (15)

1. Champlin RE, Gale RP (1987) Acute myelogenous leukemia: recent advances in therapy. Blood 69:1551-1562
2. Estey EH, Keating MJ, McCredie KB, Gehan EA, Freireich EJ (1982) Causes of initial remission induction failure in acute myelogenous leukemia. Blood 60:309-315
3. Freifield AG, Walsh T, Marshall D, et al (1995) Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidme versus imipenem. J Clin Oncol 13:165-176
4. Johnson PRE, Liu Yin JA (1993) Acute myeloid leukemia in the elderly biology and treatment. Br J Haematol 83:1-6
5. Kahn SB, Begg CB, Mazza JJ, Bennett JM, Bonner H, Glick JH (1984) Full dose versus attenuated dose daunorubicin, cytosine arabinoside and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol 2:865-870
6. Klastersky J, Glauser MP, Schimpff SC, Zinner SH, Gaya H (1986) Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother 29:263-270
7. Rai KR, Holland JF, Glidewell OJ, Weinberg V, Brunner K, Obrecht JP, Preisler HD, Nawabi IW, Prager D, Carey RW, Cooper MR, Haurani F, Hutchison JL, Silver RT, Falkson G, Wiernik P, Hoagland HC, Bloomfield CD, James GW, Gottlieb A, Ramanan SV, Blom J, Nissen NI, Bank A, Ellison RR, Kung F, Henry P, McIntyre OR, Kaan SK (1981) Treatment of acute myelocytic leukemia: a study of Cancer and Leukemia Group B. Blood 58:1203-1212
8. Rees JKH, Gray RG, Swirsky D, Hayhoe FG (1986) Principal results of the medical research council's 8th acute myeloid leukemia trial. Lancet II:1236-1241
9. Rossini F, Pioltelli P, Mingozzi S, Bregani R, Vigano F, Bolis S, Casaroli I, Lanzi E, Pogliani EM, Corneo G (1994) Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors. Support Care Cancer 2:259-265
10. Rothstein G (1993) Hematopoiesis in the aged: a model of hematopoietic dysregulation? Blood 82:2601-2604
11. Schimpff SC (1995) Infections in cancer patients. In: Mandell GL, Douglas RG Jr, Benett JE (eds) Principles and practice of infectious diseases. Churchill Livingstone, Edinburgh London New York, pp 2666-2675
12. Tilly H, Castaigne S, Bordessoule D, Casassus P, La Prise PY, Tertian G, Desablens B, Henry-Amar M, Degos L (1990) Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol 8:272-279
13. Tirelli U, Zagonel V, Serraino D, Thomas J, Hoerni B, Tangury A, Ruhl U, Bey P, Tubiana N, Breed WP (1988) Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. J Clin Oncol 6:1708-1713
14. Yates J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchison JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF (1982) Cytosine arabinoside with daunurubicin or adriamycin for therapy of acute myelocytic leukemia. A CALGB study. Blood 60:454-462
15. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer (1993) Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 119:584-593